查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825943

2025年全球心臟肌钙蛋白市场报告

Cardiac Troponin Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，心肌肌钙蛋白市场快速扩张，市场规模从2024年的38.5亿美元成长至2025年的42.4亿美元，复合年增长率为10.3%。预测期内的增长可归因于心血管疾病盛行率的上升、心臟病认知度的提高和早期诊断的提升、新兴市场医疗基础设施的不断扩展、老年人口的增长以及高灵敏度心肌肌钙蛋白检测方法的普及。

预计未来几年，心肌肌钙蛋白市场规模将快速成长，到2029年将达到62.9亿美元，复合年增长率为10.3%。预测期内的增长可归因于生活方式相关心血管疾病患病率的上升、医院心臟科室的扩建、家庭医疗保健的普及、个性化医疗的增长以及对更高效、更具成本效益的诊断解决方案的需求。预测期内的主要趋势包括：采用机器学习演算法进行心臟护理数据解读、心肌肌钙蛋白的应用扩展到急性冠状动脉症候群之外、用于同时分析生物标誌物的多重检测技术的进步、除肌钙蛋白外的新型生物标誌物的开发以及个性化医疗。

心肌肌钙蛋白是指存在于心肌中的一组蛋白质，在调节心臟收缩中扮演关键角色。这些肌钙蛋白是肌原纤维蛋白的组成部分，负责管理肌动蛋白和肌凝蛋白之间的相互作用，而这种相互作用对于肌肉收缩至关重要。它们被用作诊断心臟损伤的生物标记物，尤其是在心臟病发作的情况下。

肌钙蛋白I是一种存在于心肌细胞中的蛋白质，有助于调节肌肉收缩。血液中肌钙蛋白I水平升高可能提示心臟损伤或应激，因此其对于准确的心臟诊断至关重要。此检测可在实验室环境中进行，也可在照护现场(PoC) 进行，适用于急性冠状动脉症候群、心肌梗塞和郁血性心臟衰竭等情况。此检测的最终使用者包括医院、诊断中心和居家医疗保健机构。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗保健领域产生了重大影响，尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司係列报告中的最新一份，该系列报告提供心臟肌钙蛋白市场统计数据，例如全球市场规模、区域份额、竞争对手的心臟肌钙蛋白市场份额、详细的心臟肌钙蛋白细分市场、市场趋势和商业机会，以及您在心臟肌钙蛋白行业取得成功所需的数据。本心臟肌钙蛋白市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年10.3%的成长预测较先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致韩国和丹麦开发的高敏肌钙蛋白检测和就地检验平台价格上涨，从而延长排除心肌梗塞的时间，进而扰乱美国的急救医疗。由于互惠关税以及贸易紧张局势和限制措施的加剧对全球经济和贸易的负面影响，贸易摩擦的影响也将更加广泛。

心臟相关疾病盛行率的上升预计将推动心肌肌钙蛋白市场的未来成长。这些疾病包括各种影响心臟结构和功能的心血管疾病，例如冠状动脉疾病、心臟衰竭、心律不整和先天性心臟疾病。导致盛行率上升的因素包括人口老化、久坐不动的生活方式、不健康的饮食以及肥胖和高血压发病率的上升。心肌肌钙蛋白在诊断心臟相关疾病中发挥关键作用，因为它是识别心肌损伤的敏感生物标记物，尤其是在心臟病发作和其他心臟疾病中。例如，根据新加坡移民与关卡局和卫生署发布的2023年出生和死亡登记报告，因缺血性心臟疾病死亡的人数为5,302人，较2022年的5,290人略有增加。因此，心臟病患病率的上升预计将推动心肌肌钙蛋白市场的发展。

心肌肌钙蛋白市场的主要参与企业正专注于开发新技术，例如基于人类血清的品管，以透过多参数控制来提高高灵敏度肌钙蛋白测试的准确性和可靠性。这种品管方法利用已知肌钙蛋白浓度的人血清来检验测试性能。例如，2023 年 5 月，美国生物技术研究公司 Bio-Rad Laboratories, Inc. 推出了 Cardiac Advance，这是一种专门针对高灵敏度肌钙蛋白测试的多参数品管系统。这些以人类血清为基础的液体控製品有 InteliQ 3mL 管、Liquichek 3mL 标准品和 2.5mL 紧凑型管瓶。这些产品包括 10 种心臟分析物，包括肌钙蛋白、CK-MB、BNP/proBNP 和肌红蛋白，并与西门子和罗氏测试平台相容。这些产品在美国、欧洲和一些亚洲市场销售。

2022年2月，瑞典医疗设备製造商Prolight Diagnostics AB以578万美元收购了Psyros Diagnostics Ltd.。此次收购旨在将Psyros Diagnostics先进的单分子计数技术整合到Prolight Diagnostics的产品中，以开发高灵敏度、快速且经济高效的照护现场（POC）解决方案。此举增强了公司在各个临床领域的能力，并巩固了在POC市场的地位。总部位于英国的Psyros Diagnostics Ltd.开发了Psyros POC系统，这是一种用于测量心肌肌钙蛋白生物标记的设备。

心肌肌钙蛋白市场涵盖诊断试剂、检测套组、就地检验设备和高敏感肌钙蛋白检测的销售。该市场的价值指的是“出厂价”，即产品製造商或创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球心臟肌钙蛋白：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球心臟肌钙蛋白市场：成长率分析
  • 全球心肌肌钙蛋白市场表现：规模与成长，2019-2024
  • 全球心肌肌钙蛋白市场预测：规模与成长，2024-2029，2034
  • 全球心肌肌钙蛋白：总目标市场（TAM）

第六章 市场细分

  • 全球心肌肌钙蛋白市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 肌钙蛋白I
  • 肌钙蛋白T
  • 全球心肌肌钙蛋白市场（依测试地点、表现和预测）2019-2024、2024-2029、2034
  • 实验室
  • 照护现场检验 (POC)
  • 全球心肌肌钙蛋白市场的应用、表现与预测，2019-2024年、2024-2029、2034年
  • 急性冠状动脉症候群
  • 心肌梗塞
  • 郁血性心臟衰竭衰竭
  • 其他的
  • 全球心肌肌钙蛋白市场终端用户、绩效及预测（2019-2024、2024-2029、2034）
  • 医院
  • 诊断中心
  • 居家照护环境
  • 其他的
  • 全球心肌肌钙蛋白市场：肌钙蛋白 I 细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 心肌肌钙蛋白I（cTnI）
  • 肌钙蛋白I
  • 全球心肌肌钙蛋白市场：肌钙蛋白 T 细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 心肌肌钙蛋白T（cTnT）
  • 骨骼肌肌钙蛋白T

第七章 区域和国家分析

  • 全球心肌肌钙蛋白市场：依地区、绩效及预测，2019-2024、2024-2029、2034
  • 全球心肌肌钙蛋白市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 心臟肌钙蛋白市场：竞争格局
  • 心臟肌钙蛋白市场：公司简介
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Merck KGaA
    • Siemens Healthineers AG

第31章：其他领先和创新企业

  • Becton Dickinson and Company
  • Laboratory Corporation of America Holdings（Labcorp）
  • Zoetis Inc.
  • bioMerieux SA
  • Beckman Coulter Inc.
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Radiometer Medical ApS
  • Randox Laboratories Ltd.
  • Fujirebio Diagnostics Inc.
  • Meso Scale Diagnostics LLC.
  • Singulex Inc.
  • Diazyme Laboratories Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年心臟肌钙蛋白市场：提供新机会的国家
  • 2029 年心臟肌钙蛋白市场：细分市场带来新机会
  • 2029年心臟肌钙蛋白市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31700u

Cardiac troponin refers to a set of proteins located in the heart muscle (myocardium) that play a crucial role in regulating heart contractions. These troponins are components of the muscle fiber proteins that manage the interaction between actin and myosin, which are vital for muscle contraction. They serve as biomarkers used for diagnosing heart injuries, particularly in the case of heart attacks.

The primary types of cardiac troponin are troponin I and troponin T. Troponin I is a protein present in heart muscle cells that aids in the regulation of muscle contractions, and increased levels of Troponin I in the bloodstream may indicate heart injury or stress, making it critical for precise cardiac diagnostics. Testing can be conducted in laboratory environments as well as through point-of-care (PoC) testing, applicable in scenarios such as acute coronary syndrome, myocardial infarction, and congestive heart failure, among others. The end users of this testing include hospitals, diagnostic centers, home care settings, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cardiac troponin market research report is one of a series of new reports from the business research company that provides cardiac troponin market statistics, including cardiac troponin industry global market size, regional shares, competitors with an cardiac troponin market share, detailed cardiac troponin market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac troponin industry. This cardiac troponin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac troponin market size has grown rapidly in recent years. It will grow from $3.85 billion in 2024 to $4.24 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, increasing awareness and early diagnosis of heart conditions, expanding healthcare infrastructure in emerging markets, growth in the elderly population, introduction of high-sensitivity cardiac troponin assays.

The cardiac troponin market size is expected to see rapid growth in the next few years. It will grow to $6.29 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to rising prevalence of lifestyle-related cardiovascular conditions, expansion of cardiac care units in hospitals, increasing adoption of home healthcare, growth in personalized medicine, and demand for more efficient and cost-effective diagnostic solutions. Major trends in the forecast period include adoption of machine learning algorithms for data interpretation in cardiac care, expanding applications of cardiac troponin beyond acute coronary syndrome, advancements in multiplex testing for simultaneous biomarker analysis, development of novel biomarkers alongside troponin, and personalized medicine.

The forecast of 10.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. emergency medicine by inflating prices of high-sensitivity troponin assays and point-of-care testing platforms developed in South Korea and Denmark, resulting in prolonged MI rule-out times. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of heart-related diseases is anticipated to drive the growth of the cardiac troponin market in the future. These diseases include various cardiovascular issues such as coronary artery disease, heart failure, arrhythmias, and congenital heart defects, all of which impact the heart's structure and functionality. Factors contributing to this increasing prevalence include aging populations, sedentary lifestyles, unhealthy dietary habits, and escalating rates of obesity and hypertension. Cardiac troponin plays a vital role in diagnosing heart-related issues as it serves as a highly sensitive biomarker for identifying heart muscle damage, especially in the context of heart attacks and other cardiac events. For example, the Report on Registration of Births and Deaths 2023 from Singapore's Immigration and Checkpoints Authority and Ministry of Health indicated that deaths from ischemic heart diseases totaled 5,302, marking a slight rise from 5,290 in 2022. Thus, the growing prevalence of heart conditions is expected to boost the cardiac troponin market.

Key players in the cardiac troponin market are concentrating on developing new technologies, such as human serum-based quality control, to enhance the accuracy and reliability of high-sensitivity troponin testing through multi-analyte controls. This quality control approach utilizes human serum with known troponin levels to validate assay performance. For instance, in May 2023, Bio-Rad Laboratories, Inc., a biotechnology research firm based in the U.S., launched Cardiac Advance, a multi-analyte quality control system specifically tailored for high-sensitivity troponin testing. These liquid, human-serum-based controls are provided in InteliQ 3-mL tubes, Liquichek 3-mL standards, and 2.5-mL compact vials. They include 10 cardiac analytes, such as troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with testing platforms from Siemens and Roche. These products are available in the U.S., Europe, and select Asian markets.

In February 2022, Prolight Diagnostics AB, a Swedish medical equipment manufacturer, acquired Psyros Diagnostics Ltd. for $5.78 million. This acquisition aims to integrate Psyros Diagnostics' advanced single-molecule counting technology into Prolight Diagnostics' offerings, resulting in the development of highly sensitive, rapid, and cost-effective point-of-care (POC) testing solutions. This move enhances their capabilities across various clinical areas and solidifies their presence in the POC market. Psyros Diagnostics Ltd., a UK-based company, has created the Psyros POC system, a device designed to measure the cardiac troponin biomarker.

Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), Zoetis Inc., bioMerieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC

North America was the largest region in the cardiac troponin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac troponin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac troponin market consists of sales of diagnostic assays, test kits, point-of-care testing devices, and high-sensitivity troponin tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Troponin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac troponin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac troponin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac troponin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Troponin I; Troponin T
  • 2) By Location Of Testing: Laboratory Setting; Point Of Care (Poc) Testing
  • 3) By Application: Acute Coronary Syndrome; Myocardial Infraction; Congestive Heart Failure; Other Applications
  • 4) By End User: Hospitals; Diagnostic Centers; Homecare Setting; Other End Users
  • Subsegments:
  • 1) By Troponin I: Cardiac Troponin I (cTnI); Muscle Troponin I
  • 2) By Troponin T: Cardiac Troponin T (cTnT); Skeletal Troponin T
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Siemens Healthineers AG; Becton Dickinson and Company; Laboratory Corporation of America Holdings (Labcorp); Zoetis Inc.; bioMerieux SA; Beckman Coulter Inc.; QuidelOrtho Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Radiometer Medical ApS; Randox Laboratories Ltd.; Fujirebio Diagnostics Inc.; Meso Scale Diagnostics LLC.; Singulex Inc.; Diazyme Laboratories Inc.; Response Biomedical Corporation; Eurolyser Diagnostica GmbH; LifeSign LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Troponin Market Characteristics

3. Cardiac Troponin Market Trends And Strategies

4. Cardiac Troponin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiac Troponin Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac Troponin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac Troponin Market Growth Rate Analysis
  • 5.4. Global Cardiac Troponin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac Troponin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac Troponin Total Addressable Market (TAM)

6. Cardiac Troponin Market Segmentation

  • 6.1. Global Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Troponin I
  • Troponin T
  • 6.2. Global Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Setting
  • Point Of Care (Poc) Testing
  • 6.3. Global Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acute Coronary Syndrome
  • Myocardial Infraction
  • Congestive Heart Failure
  • Other Applications
  • 6.4. Global Cardiac Troponin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centres
  • Homecare Setting
  • Other End Users
  • 6.5. Global Cardiac Troponin Market, Sub-Segmentation Of Troponin I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Troponin I (cTnI)
  • Muscle Troponin I
  • 6.6. Global Cardiac Troponin Market, Sub-Segmentation Of Troponin T, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Troponin T (cTnT)
  • Skeletal Troponin T

7. Cardiac Troponin Market Regional And Country Analysis

  • 7.1. Global Cardiac Troponin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac Troponin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Troponin Market

  • 8.1. Asia-Pacific Cardiac Troponin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Troponin Market

  • 9.1. China Cardiac Troponin Market Overview
  • 9.2. China Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Troponin Market

  • 10.1. India Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Troponin Market

  • 11.1. Japan Cardiac Troponin Market Overview
  • 11.2. Japan Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Troponin Market

  • 12.1. Australia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Troponin Market

  • 13.1. Indonesia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Troponin Market

  • 14.1. South Korea Cardiac Troponin Market Overview
  • 14.2. South Korea Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Troponin Market

  • 15.1. Western Europe Cardiac Troponin Market Overview
  • 15.2. Western Europe Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Troponin Market

  • 16.1. UK Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Troponin Market

  • 17.1. Germany Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Troponin Market

  • 18.1. France Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Troponin Market

  • 19.1. Italy Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Troponin Market

  • 20.1. Spain Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Troponin Market

  • 21.1. Eastern Europe Cardiac Troponin Market Overview
  • 21.2. Eastern Europe Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Troponin Market

  • 22.1. Russia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Troponin Market

  • 23.1. North America Cardiac Troponin Market Overview
  • 23.2. North America Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Troponin Market

  • 24.1. USA Cardiac Troponin Market Overview
  • 24.2. USA Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Troponin Market

  • 25.1. Canada Cardiac Troponin Market Overview
  • 25.2. Canada Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Troponin Market

  • 26.1. South America Cardiac Troponin Market Overview
  • 26.2. South America Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Troponin Market

  • 27.1. Brazil Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Troponin Market

  • 28.1. Middle East Cardiac Troponin Market Overview
  • 28.2. Middle East Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Troponin Market

  • 29.1. Africa Cardiac Troponin Market Overview
  • 29.2. Africa Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Troponin Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Troponin Market Competitive Landscape
  • 30.2. Cardiac Troponin Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Troponin Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Laboratory Corporation of America Holdings (Labcorp)
  • 31.3. Zoetis Inc.
  • 31.4. bioMerieux SA
  • 31.5. Beckman Coulter Inc.
  • 31.6. QuidelOrtho Corporation
  • 31.7. Sysmex Corporation
  • 31.8. Bio-Rad Laboratories Inc.
  • 31.9. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.10. Radiometer Medical ApS
  • 31.11. Randox Laboratories Ltd.
  • 31.12. Fujirebio Diagnostics Inc.
  • 31.13. Meso Scale Diagnostics LLC.
  • 31.14. Singulex Inc.
  • 31.15. Diazyme Laboratories Inc.

32. Global Cardiac Troponin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Troponin Market

34. Recent Developments In The Cardiac Troponin Market

35. Cardiac Troponin Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac Troponin Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Troponin Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Troponin Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer